2023
High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan
Sanaubarova A, Pujol-Hodge E, Dzissyuk N, Lemey P, Vermund S, Brown A, Ali S. High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan. Viruses 2023, 15: 1407. PMID: 37515095, PMCID: PMC10384832, DOI: 10.3390/v15071407.Peer-Reviewed Original ResearchConceptsAntiretroviral therapySubtype A6Drug-resistant mutationsDrug resistanceEffective antiretroviral therapySuppressive antiretroviral therapyAntiretroviral drug resistanceDrug resistance monitoringHigh-level drug resistanceDrug regimensHIV incidenceHIV epidemicHIV-1Sustained transmissionMolecular epidemiologySubtypesPLHIVHIVG190SDifferent mutational pathwaysMutationsK101ED67NHigh levelsA62V
2022
Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan
Mukhatayeva A, Mustafa A, Dzissyuk N, Issanov A, Mukhatayev Z, Bayserkin B, Vermund SH, Ali S. Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan. Scientific Reports 2022, 12: 17195. PMID: 36229577, PMCID: PMC9562405, DOI: 10.1038/s41598-022-22163-7.Peer-Reviewed Original Research
2017
Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis
Tao J, Vermund SH, Qian HZ. Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis. AIDS And Behavior 2017, 22: 1542-1550. PMID: 28439754, PMCID: PMC7942230, DOI: 10.1007/s10461-017-1776-8.Peer-Reviewed Original ResearchConceptsAntiretroviral therapySubgroup analysisEligible studiesART useAntiretroviral therapy useProspective study designSmall-study effectsPooled sample sizeOdds ratio estimatesPublication bias analysesTherapy usePooled prevalenceEgger's testConference abstractsFunnel plotPLHIVElectronic databasesMeta-AnalysisPublication biasStudy designDepressionModerator analysesHIVBias analysisRatio estimates